<?xml version="1.0" encoding="UTF-8"?>
<p>Interesting questions arise about quasispecies when studying control of RNA viruses. Ribavirin is a drug used as an antiviral therapy, which acts as a mutagenic agent for some RNA viruses (
 <xref rid="b44" ref-type="ref">Chung et al. [2007]</xref>, 
 <xref rid="b76" ref-type="ref">Graci et al. [2008]</xref>, 
 <xref rid="b77" ref-type="ref">Grand‐Pérez et al. [2002]</xref>). To eradicate an RNA virus, ribavirin therapy is given to patients in the hope that it will lead to a nonviable pathogen referred to as lethal mutagenesis (
 <xref rid="b44" ref-type="ref">Chung et al. [2007]</xref>, 
 <xref rid="b76" ref-type="ref">Graci et al. [2008]</xref>). In theory, as the mutation rates increase, the dominant strain changes to another strain (an error catastrophe) or results in complete eradication of all strains (extinction catastrophe) (
 <xref rid="b36" ref-type="ref">Bull et al. [2005]</xref>).
</p>
